Ayr Wellness (OTCMKTS:AYRWF – Free Report) had its target price trimmed by Roth Mkm from $3.50 to $3.00 in a research note published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.
Separately, Roth Capital raised shares of Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th.
Read Our Latest Stock Analysis on AYRWF
Ayr Wellness Stock Down 1.3 %
Ayr Wellness Company Profile
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Recommended Stories
- Five stocks we like better than Ayr Wellness
- Stock Dividend Cuts Happen Are You Ready?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Significance of Brokerage Rankings in Stock Selection
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Conference Calls and Individual Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.